A detailed history of Traub Capital Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Traub Capital Management LLC holds 3,225 shares of INCY stock, worth $335,883. This represents 0.27% of its overall portfolio holdings.

Number of Shares
3,225
Previous 3,298 2.21%
Holding current value
$335,883
Previous $225 Million 21.78%
% of portfolio
0.27%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 30, 2025

SELL
$67.27 - $86.96 $4,910 - $6,348
-73 Reduced 2.21%
3,225 $274 Million
Q2 2025

Aug 11, 2025

BUY
$55.17 - $71.22 $181,950 - $234,883
3,298 New
3,298 $225 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Traub Capital Management LLC Portfolio

Follow Traub Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traub Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traub Capital Management LLC with notifications on news.